The US Polyethylene Glycol (PEG) Market was valued at USD 870 Million in 2025 and is projected to reach USD 1,710 Million by 2035, growing at a CAGR of 6.4% from 2024 to 2035. Driven by robust expansion in pharmaceutical, cosmetic, and industrial applications, the market is witnessing rapid innovation and capacity expansion among leading industry players.
The economic impact of tariffs on "US Polyethylene Glycol Market".
Market Growth Drivers
Growing Demand in Pharmaceutical Industry: Polyethylene glycol is widely used as a solvent, ointment base, and laxative in the pharmaceutical sector. The growing incidence of chronic diseases and increased drug production in the US have led to substantial PEG consumption. Companies like Dow Chemical Company and LyondellBasell are investing in expanding their PEG product portfolios specifically for pharmaceutical applications, driven by regulatory approvals and accelerating drug development activities. The COVID-19 pandemic also led to a spike in demand for PEG as a component in vaccine and drug formulations.
Expanding Applications in Personal Care and Cosmetics: PEG is a preferred ingredient in skincare, haircare, and personal hygiene products due to its moisture-retaining and surfactant properties. The rising consumer focus on health, grooming, and wellness, especially within urban populations, has accelerated the adoption of PEG by manufacturers such as BASF SE and Huntsman Corporation. New product launches featuring PEG-based emulsifiers and creams are supporting steady market growth across the US cosmetic industry.
Market Trends
Sustainable and Bio-based PEG Production: The US market is seeing significant investments in sustainable PEG production methods. Companies like Dow Inc. and SABIC are focusing on developing bio-based Polyethylene Glycol derived from renewable feedstocks to meet increasing regulatory and consumer demand for green chemicals. These initiatives are expected to drive long-term growth while reducing the carbon footprint associated with traditional petrochemical production.
Increase in Industrial Applications and Process Innovations: Beyond healthcare and cosmetics, PEG is increasingly utilized in paints, coatings, adhesives, and as a chemical intermediate. Kellin Chemicals and Lotte Chemical USA have recently introduced innovative PEG grades with improved solubility and functional attributes tailored for industrial uses. This trend is enhancing the versatility of PEG, supporting its integration into new manufacturing and processing solutions.
Market Opportunity
Emerging Use in Biopharmaceuticals: The surge in biologics and gene therapy development in the US pharmaceutical space represents a key opportunity for specialty PEG formulations. Companies such as Thermo Fisher Scientific are investing in PEGylation technologies that enhance drug delivery and stability, unlocking novel applications in next-generation therapeutics.
3D Printing and Additive Manufacturing: PEG’s role as a binder and plasticizer in 3D printing materials is poised to grow with the US manufacturing sector’s shift toward digital production techniques. Chemical manufacturers like Evonik are exploring advanced PEG blends for additive manufacturing of medical devices and consumer goods.
The market revenue chart illustrates steady growth in the US Polyethylene Glycol market from 2020 to 2035. Revenues stood at USD 580 Million in 2020 and have consistently increased year-over-year, driven by expanding pharmaceutical and cosmetic demand and industrial diversification. The chart highlights a robust CAGR of 6.4%, with projected revenues reaching USD 1,710 Million by 2035. Key growth inflection points correspond to increased drug approvals and shifting consumer preferences, supporting optimistic long-term forecasts for the PEG market.
US Polyethylene Glycol Market Share by Region (2025)
The pie chart for 2025 shows that the South region leads the US Polyethylene Glycol market with a 31% share, largely due to its concentration of chemical manufacturing plants and major healthcare facilities. The Midwest follows at 27%, benefiting from its strong pharmaceutical production base. The West, with a 19% share, is registering growth owing to robust biotechnology and personal care industries, while the Northeast captures 15% and the Southeast completes the market with 8%. Regional dynamics reflect differences in end-user industries and infrastructure across the US.
Recent Developments in US Polyethylene Glycol Market
In March 2024, Dow Inc. announced the expansion of its Polyethylene Glycol production facility in Texas by 30%. This investment aims to meet growing US pharmaceutical sector demand and support innovation in green PEG chemistry. The upgraded facility will increase supply chain security and accelerate delivery of both traditional and bio-based PEG grades.
In May 2024, BASF SE introduced a new line of cosmetic-grade PEG emulsifiers specifically designed for high-end skincare applications. The launch targets the premium personal care market in the US amid rising trends for clean-label and multifunctional cosmetic ingredients, ensuring BASF’s leadership in topical formulation innovation.
In February 2024, LyondellBasell signed a strategic partnership with a leading US pharmaceutical firm to supply high-purity PEG for injectable and oral drug formulations. The collaboration will focus on compliance with new US FDA quality standards while supporting the development of more effective drug delivery systems tailored to the US market.
Press Releases